Asuragen is a molecular diagnostics company driving better patient management in oncology and genetic disorders through best-in-class clinical testing solutions. The company discovers, develops and commercializes diagnostic products for use in clinical laboratories and to serve our Bio/Pharma partners’ diagnostic needs. Asuragen’s development of innovative diagnostic products will help transform medicine by improving clinical outcomes and health economics.